1-4 of 4
Gina B. Scott
Close
Sort by
Journal Articles

Combination Therapy with Reovirus and Immunomodulatory Drugs Induces Direct Oncolytic and Immune-Mediated Killing of Multiple Myeloma Cells and Overcomes Stromal-Mediated Microenvironmental Protection

Christopher Parrish, MD, Gina B Scott, PhD, Matt Coffey, Alan Melcher, MD, Fiona Errington-Mais, PhD, Gordon Cook, MD
Journal: Blood
Blood (2014) 124 (21): 4778.
https://doi.org/10.1182/blood.V124.21.4778.4778
Published: 2014
Journal Articles

Th 17 Cells Are Increased in the Bone Marrow but Not the Peripheral Blood in Multiple Myeloma and Demonstrate Defective Functionality and Aberrant Phenotypes

Christopher Parrish, MD, Gina B Scott, PhD, Graham Cook, PhD, Gordon Cook, MD
Journal: Blood
Blood (2014) 124 (21): 3420.
https://doi.org/10.1182/blood.V124.21.3420.3420
Published: 2014
Journal Articles

Lenalidomide Redresses the Effector T Cell:T reg Cell Imbalance in Patients with Multiple Myeloma.

Clive R Carter, Christopher Parrish, MD, Sylvia Feyler, MD PhD, Natuley Smalle, Gina B Scott, PhD, Charlotte Kallmeyer, MD PhD, Philip Wood, MD DPhil, Gordon Cook, MD PhD
Journal: Blood
Blood (2012) 120 (21): 2977.
https://doi.org/10.1182/blood.V120.21.2977.2977
Published: 2012
Journal Articles

Effect of combined dexamethasone/lenalidomide therapy on NK cell–receptor levels in myeloma patients

Clive R. Carter, Sylvia Feyler, Natuley Smalle, Gina B. Scott, Christopher Parrish, Katherine Cullen, Charlotte Kallmeyer, Philip M. Wood, Gordon Cook
Journal: Blood
Blood (2011) 118 (24): 6465–6466.
https://doi.org/10.1182/blood-2011-08-372680
Published: 2011